FDA moves to real-time clinical trial patient monitoring, faster drug review

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical ...
Fierce Biotech

FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...

Amgen, Astra launch real-time trials as FDA to expedite drug development using AI

The U.S. FDA announced on Tuesday that Amgen (AMGN) and AstraZeneca (AZN) have initiated real-time clinical trials as the agency seeks to launch a pilot program designed to accelerate drug development ...
Florida Today

Ainnocence and Phase Advance Enter Industry-First AI Collab to Reduce Drug Development Timeline and Clinical Trial Risk

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
Morning Overview on MSN

J&J says AI is cutting drug-discovery lead times roughly in half

At a Reuters conference earlier this year, Johnson & Johnson chief information officer Jim Swanson offered a striking number: ...